Importantly, WISP1 could be a paracrine inhibitor of type 1 cell-mediated immunity via suppression of IL-12 signaling and promotion of type 2 immunity to promote the transformation of invasive breast cancer [7]. The gene discussed is CCN4; the disease is invasive breast carcinoma.